Zhengzhou (1)

CD79A Gene Mutation (1)

CD79B Gene Mutation (1)

Diffuse Large B Cell Lymphoma (1)

Recruiting (1)

phase 2 (1)

Henan Cancer Hospital (1)

cyclophosphamide (1)

epirubicin (1)

prednisone (1)

rituximab (1)

vincristine (1)

zanubrutinib (1)

drug (1)

Other (1)

Interventional (1)

cd79a gene mutation

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Zhengzhou, Henan, China

Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho

Jan 22, 2022